Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New paradigms in immunosuppression.

Robert Huizinga1, Therese Voyer

  • 1Isotechnika Inc., Edmonton, Alberta. robert.huizinga@isotechnika.com

CANNT Journal = Journal ACITN
|November 5, 2003
PubMed
Summary

Transplantation immunosuppression is evolving due to donor and recipient factors. New strategies targeting co-stimulation, lymphocyte trafficking, and antibody production are emerging, but clinical application requires further evaluation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis.

Journal of the American Academy of Dermatology·2006
Same author

Update in immunosuppression.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association·2002
See all related articles

Area of Science:

  • Immunology
  • Transplant Medicine

Background:

  • Decreasing donor quality and increasing recipient comorbidities are altering transplantation protocols.
  • Current immunosuppression strategies face challenges in optimizing patient outcomes.

Purpose of the Study:

  • To review the evolving landscape of transplantation immunosuppression.
  • To highlight new therapeutic paradigms and agents in transplantation.

Main Methods:

  • Literature review of recent advancements in transplantation immunology and immunosuppression.
  • Analysis of novel targets including co-stimulation pathways, lymphocyte trafficking, and antibody production.

Main Results:

  • Emerging immunosuppressive agents target novel pathways like co-stimulation and lymphocyte homing.
  • These new agents offer potential for improved graft survival and reduced toxicity.

Conclusions:

  • The field of transplantation immunosuppression is shifting towards targeted therapies.
  • Further clinical validation is necessary to establish the role of new immunosuppressive agents in routine practice.

Related Experiment Videos